GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » YoY EBITDA Growth

Turmeric Acquisition (Turmeric Acquisition) YoY EBITDA Growth : 0.00% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Turmeric Acquisition's YoY EBITDA Growth for the quarter that ended in Jun. 2022 was 0.00%.

Turmeric Acquisition's EBITDA per Share for the three months ended in Jun. 2022 was $0.00.


Turmeric Acquisition YoY EBITDA Growth Historical Data

The historical data trend for Turmeric Acquisition's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition YoY EBITDA Growth Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
YoY EBITDA Growth
- -

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
YoY EBITDA Growth Get a 7-Day Free Trial - - - - -

Turmeric Acquisition YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Turmeric Acquisition's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-)/ | |
=N/A %

Turmeric Acquisition's YoY EBITDA Growth for the quarter that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (Q: Jun. 2022 )
=(EBITDA per Share (Q: Jun. 2022 )-EBITDA per Share (Q: Jun. 2021 )) / | EBITDA per Share (Q: Jun. 2021 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turmeric Acquisition YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Turmeric Acquisition (Turmeric Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005